Pathogenesis of Henoch-Schönlein purpura nephritis

Keith K Lau1, Hitoshi Suzuki, Jan Novak

  • 1Department of Pediatrics, McMaster University, 1200 Main Street West, HSC 3N27, Hamilton, Ontario, Canada. keithklou@gmail.com

Insights

Henoch-Schönlein purpura nephritis (HSPN) in children is often predicted by kidney involvement severity. Galactose-deficient IgA1 (Gd-IgA1) and anti-glycan antibodies contribute to immune complex deposition, causing kidney damage.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Rheumatology

Background:

  • Henoch-Schönlein purpura nephritis (HSPN) is a significant cause of kidney disease in children.
  • Renal involvement severity is the primary determinant of long-term outcomes in pediatric HSPN.
  • Approximately 40% of children with Henoch-Schönlein purpura (HSP) develop nephritis, typically within weeks of rash onset.

Purpose of the Study:

  • To elucidate the pathogenetic mechanisms underlying renal injury in Henoch-Schönlein purpura nephritis.
  • To investigate the role of galactose-deficient IgA1 (Gd-IgA1) in HSPN development.
  • To identify potential targets for therapeutic intervention in pediatric kidney disease.

Main Methods:

  • Review of existing literature on HSPN pathogenesis.
  • Analysis of studies investigating immune complex formation and deposition in renal tissue.
  • Exploration of the role of anti-glycan antibodies in the context of Gd-IgA1.

Main Results:

  • Galactose-deficient IgA1 (Gd-IgA1) is implicated in HSPN pathogenesis.
  • Formation of circulating immune complexes involving Gd-IgA1 and anti-glycan antibodies.
  • Deposition of these immune complexes in the renal mesangium, leading to kidney injury.

Conclusions:

  • The interaction between Gd-IgA1 and anti-glycan antibodies is a key factor in HSPN pathogenesis.
  • Mesangial deposition of immune complexes drives renal damage in children with HSPN.
  • Understanding these mechanisms is crucial for improving long-term outcomes in pediatric kidney disease.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...